SecBot SecBot
COURT-RULING ·Filed Sep 29, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 1/10
Horizonmonths Processed27d 18h ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

This is a purely administrative step. The case remains in pretrial litigation; the next substantive event will be the summary judgment motions themselves. Monitor for any ruling on those motions, which could materially affect Merck's exposure.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+5d ⚠ clustered
MRK ▼ -1.73% at T+5d
NEUTRAL call -1.73% · α vs SPY -3.65% · entry $145.31 → $142.79
Next anchor: T+20d tomorrow
Latest observation: T+17 -8.45% FF3 residual α
Entry = T+0 close
Sep 30, 2026
via day close
T+1d
-1.03%
call -1.03% · α -1.21%
$143.81
settled 25d ago
T+5d
-1.73%
call -1.73% · α -3.65%
$142.79
settled 19d ago
T+20d
Pending
tomorrow
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

This is a routine procedural stipulation and order in the antitrust case Kaiser Foundation Health Plan v. Merck, granting the parties additional page limits (35 pages for motions/oppositions, 20 for replies) for forthcoming summary judgment briefing. The order itself is a scheduling/administrative step with no substantive ruling on the merits, damages, or liability.

Court Ruling Details

Ruling Date
Sep 29, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Judge
Haywood S. Gilliam, Jr.
Case Type
antitrust
Ruling Type
procedural
Precedent Risk
LOW

Key Facts

  • The order sets page limits for summary judgment motions in a complex antitrust case (Kaiser v. Merck).
  • Each party gets 35 pages for motions and oppositions, 20 pages for replies.
  • The case is pending in the Northern District of California before Judge Haywood S. Gilliam, Jr.
  • No substantive ruling on liability, damages, or injunctive relief was made.

Financial Impact

None — procedural order only; no financial exposure quantified in the document.

Risk Factors

  • The underlying antitrust case could still result in material damages or injunctive relief if Merck loses on summary judgment or at trial.
  • No damages or settlement amounts are mentioned in this order.

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-cbf8a12e3c-MRK
28 reports for MRK
Performance horizon
75% Hit rate @ T+20 3 of 4 directional calls Went positive at some point 4 of 6 best @ T+20▲ +16.92%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Oct 22, 2026
3d ago
3/A
NEUTRAL ★ 1/10
$147.24awaiting T+20—$140.74 (−4.42%)
Oct 21, 2026
5d ago
PTAB Trial
NEUTRAL ★ 3/10
$147.24awaiting T+20—$140.74 (−4.42%)
Oct 15, 2026
11d ago
PTAB Trial
BULLISH ★ 6/10
$145.95awaiting T+20—$140.74 (−3.57%)
Oct 15, 2026
11d ago
PTAB Trial
BULLISH ★ 5/10
$145.95awaiting T+20—$140.74 (−3.57%)
Oct 13, 2026
13d ago
8-K
NEUTRAL ★ 2/10
$141.98awaiting T+20—$140.74 (−0.88%)
Sep 29, 2026
27d ago
Court Ruling
NEUTRAL ★ 1/10
$145.31awaiting T+20—$140.74 (−3.15%)
Sep 28, 2026
28d ago
Court Ruling
NEUTRAL ★ 1/10
$149.28awaiting T+20—$140.74 (−5.72%)
Sep 22, 2026
4w ago
Court Ruling
NEUTRAL ★ 3/10
$148.08 $149.88▲ +1.22%▲ +0.53%$140.74 (−4.96%)
Sep 11, 2026
6w ago
Court Ruling
NEUTRAL ★ 1/10
$144.85 $145.45▲ +0.41%▼ −1.85%$140.74 (−2.84%)
Sep 9, 2026
6w ago
Court Ruling
NEUTRAL ★ 1/10
$144.71 $142.38▼ −1.61%▼ −3.73%$140.74 (−2.75%)
Showing 10 of 28

US Market Status

Market Open — Closes in 1h 12m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Sep 29, 2026